These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 26172294

  • 1. NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells.
    Han D, Wei W, Chen X, Zhang Y, Wang Y, Zhang J, Wang X, Yu T, Hu Q, Liu N, You Y.
    Oncotarget; 2015 Sep 22; 6(28):26119-28. PubMed ID: 26172294
    [Abstract] [Full Text] [Related]

  • 2. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
    Yang W, Xia Y, Cao Y, Zheng Y, Bu W, Zhang L, You MJ, Koh MY, Cote G, Aldape K, Li Y, Verma IM, Chiao PJ, Lu Z.
    Mol Cell; 2012 Dec 14; 48(5):771-84. PubMed ID: 23123196
    [Abstract] [Full Text] [Related]

  • 3. PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation.
    Azoitei N, Becher A, Steinestel K, Rouhi A, Diepold K, Genze F, Simmet T, Seufferlein T.
    Mol Cancer; 2016 Jan 06; 15():3. PubMed ID: 26739387
    [Abstract] [Full Text] [Related]

  • 4. GRP78 is implicated in the modulation of tumor aerobic glycolysis by promoting autophagic degradation of IKKβ.
    Li Z, Wang Y, Newton IP, Zhang L, Ji P, Li Z.
    Cell Signal; 2015 Jun 06; 27(6):1237-45. PubMed ID: 25748049
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.
    Wilk A, Wyczechowska D, Zapata A, Dean M, Mullinax J, Marrero L, Parsons C, Peruzzi F, Culicchia F, Ochoa A, Grabacka M, Reiss K.
    Mol Cell Biol; 2015 Jan 06; 35(1):182-98. PubMed ID: 25332241
    [Abstract] [Full Text] [Related]

  • 6. Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells.
    de Wit RH, Mujić-Delić A, van Senten JR, Fraile-Ramos A, Siderius M, Smit MJ.
    Oncotarget; 2016 Oct 18; 7(42):67966-67985. PubMed ID: 27602585
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of autophagy promotes metastasis and glycolysis by inducing ROS in gastric cancer cells.
    Qin W, Li C, Zheng W, Guo Q, Zhang Y, Kang M, Zhang B, Yang B, Li B, Yang H, Wu Y.
    Oncotarget; 2015 Nov 24; 6(37):39839-54. PubMed ID: 26497999
    [Abstract] [Full Text] [Related]

  • 8. Human steroid sulfatase enhances aerobic glycolysis through induction of HIF1α and glycolytic enzymes.
    Shin S, Kwon YJ, Ye DJ, Baek HS, Kwon TU, Kim D, Chun YJ.
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep 01; 1865(9):2464-2474. PubMed ID: 31195119
    [Abstract] [Full Text] [Related]

  • 9. PKM2 contributes to cancer metabolism.
    Wong N, Ojo D, Yan J, Tang D.
    Cancer Lett; 2015 Jan 28; 356(2 Pt A):184-91. PubMed ID: 24508027
    [Abstract] [Full Text] [Related]

  • 10. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis.
    Feng J, Dai W, Mao Y, Wu L, Li J, Chen K, Yu Q, Kong R, Li S, Zhang J, Ji J, Wu J, Mo W, Xu X, Guo C.
    J Exp Clin Cancer Res; 2020 Jan 30; 39(1):24. PubMed ID: 32000827
    [Abstract] [Full Text] [Related]

  • 11. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
    Wang X, Zhang H, Yang H, Bai M, Ning T, Deng T, Liu R, Fan Q, Zhu K, Li J, Zhan Y, Ying G, Ba Y.
    Mol Oncol; 2020 Mar 30; 14(3):539-555. PubMed ID: 31901148
    [Abstract] [Full Text] [Related]

  • 12. A PKM2 signature in the failing heart.
    Rees ML, Subramaniam J, Li Y, Hamilton DJ, Frazier OH, Taegtmeyer H.
    Biochem Biophys Res Commun; 2015 Apr 10; 459(3):430-6. PubMed ID: 25735978
    [Abstract] [Full Text] [Related]

  • 13. Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [18F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression.
    Patel CB, Beinat C, Xie Y, Chang E, Gambhir SS.
    Neoplasia; 2021 Jan 10; 23(1):58-67. PubMed ID: 33221711
    [Abstract] [Full Text] [Related]

  • 14. Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms.
    Liu J, Wu N, Ma L, Liu M, Liu G, Zhang Y, Lin X.
    PLoS One; 2014 Jan 10; 9(3):e91606. PubMed ID: 24626155
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
    Taniguchi K, Sugito N, Kumazaki M, Shinohara H, Yamada N, Nakagawa Y, Ito Y, Otsuki Y, Uno B, Uchiyama K, Akao Y.
    Cancer Lett; 2015 Jul 10; 363(1):17-27. PubMed ID: 25818238
    [Abstract] [Full Text] [Related]

  • 16. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism.
    Wang HJ, Hsieh YJ, Cheng WC, Lin CP, Lin YS, Yang SF, Chen CC, Izumiya Y, Yu JS, Kung HJ, Wang WC.
    Proc Natl Acad Sci U S A; 2014 Jan 07; 111(1):279-84. PubMed ID: 24344305
    [Abstract] [Full Text] [Related]

  • 17. Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer.
    Yadav S, Bhagat SD, Gupta A, Samaiya A, Srivastava A, Shukla S.
    BMC Cancer; 2019 Nov 01; 19(1):1031. PubMed ID: 31675998
    [Abstract] [Full Text] [Related]

  • 18. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
    Feng J, Wu L, Ji J, Chen K, Yu Q, Zhang J, Chen J, Mao Y, Wang F, Dai W, Xu L, Wu J, Guo C.
    J Exp Clin Cancer Res; 2019 May 17; 38(1):204. PubMed ID: 31101057
    [Abstract] [Full Text] [Related]

  • 19. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
    Luan W, Wang Y, Chen X, Shi Y, Wang J, Zhang J, Qian J, Li R, Tao T, Wei W, Hu Q, Liu N, You Y.
    Oncotarget; 2015 May 30; 6(15):13006-18. PubMed ID: 25948776
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis.
    Okamoto H, Iwamoto T, Kotake S, Momohara S, Yamanaka H, Kamatani N.
    Clin Exp Rheumatol; 2005 May 30; 23(3):323-30. PubMed ID: 15971419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.